Glenmark Pharma soars as its arm receives USFDA’s approval for Lacosamide Tablets
Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at Rs. 445.00 and has touched a high and low of Rs. 457.85 and Rs. 445.00 respectively. So far 42623 shares were traded on the counter. The BSE … Read more